Durham’s CoLucid Pharmaceuticals raised $37 million to continue development of a drug for migraines and headache pain.
It’s an important area of need. Some 36 million people suffer from migraines – or more than those who have asthma or diabetes combined. Migraine is ranked as the seventh highest cause of global disability and is one of the top 10 causes of disability in 14 of 21 world regions studied, according to findings by the Global Burden of Disease Survey 2010 conducted by the World Health…
